Iovance Biotherapeutics (IOVA) Debt Ratio (2012 - 2024)

Iovance Biotherapeutics (IOVA) posted quarterly Debt Ratio of 0.0 for Q4 2024, down 14.29% year-over-year from 0.0 in Q1 2024, and down 4.46% quarter-over-quarter from 0.0 in Q1 2024.

Iovance Biotherapeutics (IOVA) Debt Ratio (2012 - 2024) Analysis & Trends

Iovance Biotherapeutics (IOVA) has reported Debt Ratio for 5 consecutive years, with 0.0 the latest figure, recorded in Q4 2024.

  • In Q4 2024, Debt Ratio fell 14.29% year-over-year to 0.0; the TTM figure through Dec 2024 stood at 0.0 (down 14.29% YoY), while the FY2024 annual figure was 0.0, down 14.29% from the prior year.
  • Debt Ratio slipped to 0.0 in Q4 2024 per IOVA's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.0 in Q3 2022 and bottomed at 0.0 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.0 across 4 years, with a median of 0.0 in 2021.
  • Annual changes were most pronounced in 2022 — Debt Ratio jumped 51.82% — and 2023, when it slumped 35.95%.
  • Iovance Biotherapeutics' Debt Ratio stood at 0.0 in 2021, then advanced by 17.07% to 0.0 in 2022, then dropped by 14.91% to 0.0 in 2023, then declined by 14.29% to 0.0 in 2024.
  • Business Quant data shows IOVA's Debt Ratio at 0.0 in Q4 2024, 0.0 in Q1 2024, and 0.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Iovance Biotherapeutics 3.16 Bn 2.86 Bn 55.72 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2012 8.50
Sep 30, 2012 17.43